Found: 14
Select item for more details and to access through your institution.
Osteocytes and Paget's Disease of Bone.
- Published in:
- Current Osteoporosis Reports, 2024, v. 22, n. 2, p. 266, doi. 10.1007/s11914-024-00863-5
- By:
- Publication type:
- Article
Class 1 HDAC and HDAC6 inhibition inversely regulates CD38 induction in myeloma cells via interferon‐α and ATRA.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 5, p. 969, doi. 10.1111/bjh.15673
- By:
- Publication type:
- Article
Pim‐2 is a critical target for treatment of osteoclastogenesis enhanced in myeloma.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 4, p. 581, doi. 10.1111/bjh.14388
- By:
- Publication type:
- Article
Unique anti‐myeloma activity by thiazolidine‐2,4‐dione compounds with Pim inhibiting activity.
- Published in:
- British Journal of Haematology, 2018, v. 180, n. 2, p. 246, doi. 10.1111/bjh.15033
- By:
- Publication type:
- Article
The Roles of ROS Generation in RANKL-Induced Osteoclastogenesis: Suppressive Effects of Febuxostat.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 929, doi. 10.3390/cancers12040929
- By:
- Publication type:
- Article
P-005: Novel strategy of elotuzumab and zoledronic acid with Th1-like γδT cells against myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S41, doi. 10.1016/S2152-2650(21)02139-X
- By:
- Publication type:
- Article
Synergistic targeting of Sp1 in myeloma cells with hyperthermia plus proteasome inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e132, doi. 10.1016/j.clml.2019.09.219
- By:
- Publication type:
- Article
A progressive auto-amplification loop in TAK1 expression and activation in myeloma cells.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e111, doi. 10.1016/j.clml.2019.09.183
- By:
- Publication type:
- Article
Targeting myeloma metabolisms regulated by HDAC1-IRF4 axis can be a novel therapeutic strategy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2019, v. 19, p. e105, doi. 10.1016/j.clml.2019.09.173
- By:
- Publication type:
- Article
The Xanthine Oxidase Inhibitor Febuxostat Suppresses Adipogenesis and Activates Nrf2.
- Published in:
- Antioxidants, 2023, v. 12, n. 1, p. 133, doi. 10.3390/antiox12010133
- By:
- Publication type:
- Article
Mechanisms of preferential bone formation in myeloma bone lesions by proteasome inhibitors.
- Published in:
- International Journal of Hematology, 2023, v. 118, n. 1, p. 88, doi. 10.1007/s12185-023-03601-2
- By:
- Publication type:
- Article
TGF‐β‐activated kinase‐1 inhibitor LL‐Z1640‐2 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF‐α and RANKL expression.
- Published in:
- Clinical & Translational Immunology, 2022, v. 11, n. 1, p. 1, doi. 10.1002/cti2.1371
- By:
- Publication type:
- Article
Inflammatory Cytokine-Induced Muscle Atrophy and Weakness Can Be Ameliorated by an Inhibition of TGF-β-Activated Kinase-1.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 5715, doi. 10.3390/ijms25115715
- By:
- Publication type:
- Article
Persistent Activation of Calcium‐Sensing Receptor Suppresses Bone Turnover, Increases Microcracks, and Decreases Bone Strength.
- Published in:
- JBMR Plus, 2019, v. 3, n. 7, p. N.PAG, doi. 10.1002/jbm4.10182
- By:
- Publication type:
- Article